Human papillomavirus infection among young adolescents in India: Impact of vaccination

Journal of Medical Virology

Volumn 84, Issue 2, 2012, Pages 298-305

  Hussain, Showket ^a   Bharadwaj, Mausumi ^a,b   Nasare, Vilas ^a   Kumari, Malasha ^a   Sharma, Shashi ^a   Hedau, Suresh ^a   Das, Bhudev C ^a,b  

^a Institute of Cytology and Preventive Oncology ICMR   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Awareness; Cervical cancer; Education; Self urine sampling; Vaccine acceptance

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; AWARENESS; CANCER CONTROL; CHILD; DISEASE ASSOCIATION; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INDIA; MALE; MOSLEM; NORMAL HUMAN; PAPILLOMAVIRUS INFECTION; PARENTING EDUCATION; POLYMERASE CHAIN REACTION; PREVALENCE; SCHOOL CHILD; URINALYSIS; UTERINE CERVIX CANCER; VIRUS DETECTION;

ADOLESCENT; ALPHAPAPILLOMAVIRUS; CHILD; DNA, VIRAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INDIA; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 83655182717     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22261     Document Type: Article

References (49)

1. Bhatla N, Suri V, Basu P, Shastri S, Datta SK, Bi D, Descamps DJ, Bock HL. 2010. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women. J Obstet Gynaecol Res 36:123-132.
2. Biellik R, Levin C, Mugisha E, LaMontagne DS, Bingham A, Kaipilyawar S, Gandhi S. 2009. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine 27:6203-6209.
3. Bingham A, Drake JK, LaMontagne DS. 2009. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med 163:455-461.
4. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, Franceschi S. 2002. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 346:1105-1112.
5. Castellsague X, Drudis T, Canadas MP, Gonce A, Ros R, Perez JM, Quintana MJ, Munoz J, Albero G, de Sanjose S, Bosch FX. 2009. Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: A prospective study in Spain. BMC Infect Dis 9:74.
6. Costa FA, da Silva RC, Arruda LB, Duarte AJ, Casseb J. 2009. Prevalence of human papillomaviruses in urine samples of male patients infected with HIV-1 in Sao Paulo, Brazil. J Med Virol 81:2007-2011.
7. Das BC, Gopalkrishna V, Sharma JK, Roy M, Luthra UK. 1992a. Human papillomavirus DNA in urine of women with preneoplastic and neoplastic cervical lesions. Lancet 340:1417-1418.
8. Das BC, Hussain S, Nasare V, Bharadwaj M. 2008. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 26:2669-2679.
9. Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Gissmann L, Zur Hausen H, Luthra UK., 1992b. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 36:239-245.
10. Datta P, Bhatla N, Dar L, Patro AR, Gulati A, Kriplani A, Singh N. 2010. Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol 34:157-161.
11. Dell DL, Chen H, Ahmad F, Stewart DE. 2000. Knowledge about human papillomavirus among adolescents. Obstet Gynecol 96:653-656.
12. D'Hauwers K, Depuydt C, Bogers JP, Stalpaert M, Vereecken A, Wyndaele JJ, Tjalma W. 2007. Urine versus brushed samples in human papillomavirus screening: Study in both genders. Asian J Androl 9:705-710.
13. Dillard JP, Spear ME. 2010. Knowledge of human papillomavirus and perceived barriers to vaccination in a sample of US female college students. J Am Coll Health 59:186-190.
14. Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Munoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R, FUTURE Study Group I/II. 2010. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial. BMJ 341:c3493.
15. Fambrini M, Penna C, Pieralli A, Bussani C, Fallani MG, Andersson KL, Scarselli G, Marchionni M. 2008. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia. Gynecol Oncol 109:59-64.
16. Gopalkrishna V, Murthy NS, Sharma JK, Roy M, Das DK, Luthra UK, Das BC. 1995. Increased human papillomavirus infection with the increasing number of pregnancies in Indian women. J Infect Dis 171:254-255.
17. Gupta A, Arora R, Gupta S, Prusty BK, Kailash U, Batra S, Das BC. 2006. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens. J Clin Virol 37:190-194.
18. Handley J, Hanks E, Armstrong K, Bingham A, Dinsmore W, Swann A, Evans MF, McGee JO, O'Leary J. 1997. Common association of HPV 2 with anogenital warts in prepubertal children. Pediatr Dermatol 14:339-343.
19. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G, 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367:1247-1255.
20. Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM Jr. 1995. Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis 22:236-243.
21. Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC. 2006. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer 95:1250-1257.
22. Kerkar SC, Latta S, Salvi V, Mania-Pramanik J. 2011. Human Papillomavirus infection in asymptomatic population. Sex Reprod Healthc 2:7-11.
23. Kohaar I, Hussain S, Thakur N, Tiwari P, Nasare V, Batra S, Singh V, Bhambani S, Das BC, Sarkar DP, Bharadwaj M. 2009. Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women. Hum Immunol 70:222-229.
24. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, Sodhani P, Das BC, Sarkar DP, Bharadwaj M. 2007. TNFalpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 29:249-256.
25. Nnodu O, Erinosho L, Jamda M, Olaniyi O, Adelaiye R, Lawson L, Odedina F, Shuaibu F, Odumuh T, Isu N, Imam H, Owolabi O, Yaqub N, Zamani A. 2010. Knowledge and attitudes towards cervical cancer and human papillomavirus: A Nigerian pilot study. Afr J Reprod Health 14:95-108.
26. O'Leary MC, Sinka K, Robertson C, Cuschieri K, Lyman R, Lacey M, Potts A, Cubie HA, Donaghy M. 2011. HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland. Br J Cancer 104:1221-1226.
27. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peeters P, Struyf F, Wieting SL, Lehtinen MO, Dubin G. 2007. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369:2161-2170.
28. Pillai RM, Babu JM, Jissa VT, Lakshmi S, Chiplunkar SV, Patkar M, Tongaonkar H, Reddy KB, Chakka KN, Siddiqui M, Roychoudury S, Abraham P, Peedicayil A, Gnanamony M, Subashini J, Ram TS, Dey B, Singh N, Singh A, Jain SK, Jayshree RS. 2010. Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India. Int J Gynecol Cancer 20:1046-1051.
29. Pitts MK, Heywood W, Ryall R, Smith AM, Shelley JM, Richters J, Simpson JM. 2010. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women. Sex Health 7:299-303.
30. Powell J, Strauss S, Gray J, Wojnarowska F. 2003. Genital carriage of human papilloma virus (HPV) DNA in prepubertal girls with and without vulval disease. Pediatr Dermatol 20:191-194.
31. Prusty BK, Kumar A, Arora R, Batra S, Das BC. 2005. Human papillomavirus (HPV) DNA detection in self-collected urine. Int J Gynaecol Obstet 90:223-227.
32. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT. 2008. A new HPV-DNA test for cervical-cancer screening in developing regions: A cross-sectional study of clinical accuracy in rural China. Lancet Oncol 9:929-936.
33. Rama CH, Villa LL, Pagliusi S, Andreoli MA, Costa MC, Aoki AL, Longatto-Filho A, Eluf-Neto J. 2010. Awareness and knowledge of HPV, cervical cancer, and vaccines in young women after first delivery in Sao Paulo, Brazil-a cross-sectional study. BMC Womens Health 10:35.
34. Ramqvist T, Du J, Lunden M, Ahrlund-Richter S, Ferreira J, Marions L, Sparen P, Andersson S, Dalianis T. 2010. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden. Scand J Infect Dis 43:115-121.
35. Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. 2009. Perinatal transmission of human papilomavirus DNA. Virol J 6:83.
36. Saha A, Chaudhury AN, Bhowmik P, Chatterjee R. 2010. Awareness of cervical cancer among female students of premier colleges in Kolkata, India. Asian Pac J Cancer Prev 11:1085-1090.
37. Sambrook J, Fritsh EE, Maniatis T. 2001. Molecular cloninig: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, p 3.
38. Shigehara K, Sasagawa T, Kawaguchi S, Kobori Y, Nakashima T, Shimamura M, Taya T, Furubayashi K, Namiki M. 2010. Prevalence of human papillomavirus infection in the urinary tract of men with urethritis. Int J Urol 17:563-568.
39. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, Das BC. 2009. Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res 130:222-233.
40. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J. 2009. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 302:750-757.
41. Song ES, Lee HJ, Hwang TS. 2007. Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions. J Korean Med Sci 22:99-104.
42. Stanley M, Villa LL. 2008. Monitoring HPV vaccination. Vaccine 26:A24-27.
43. Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, Charvat B, Ssempijja V, Riedesel M, Oliver AE, Nowak RG, Moulton LH, Chen MZ, Reynolds SJ, Wawer MJ, Gray RH. 2009. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 360:1298-1309.
44. Tornesello ML, Loquercio G, Tagliamonte M, Rossano F, Buonaguro L, Buonaguro FM. 2010. Human papillomavirus infection in urine samples from male renal transplant patients. J Med Virol 82:1179-1185.
45. Villa LL. 2010. HPV prophylactic vaccination: The first years and what to expect from now. Cancer Lett 305:106-112.
46. Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, Olsson SE, Hoye J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom A, Elfgren K, Krogh G, Lehtinen M, Malm C, Tamms GM, Giacoletti K, Lupinacci L, Railkar R, Taddeo FJ, Bryan J, Esser MT, Sings HL, Saah AJ, Barr E. 2006. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95:1459-1466.
47. Vogtmann E, Harlow SD, Valdez AC, Valdez JC, Ponce EL. 2010. HPV knowledge in Mexican college students: Implications for intervention programmes. Health Soc Care Community 19:148-157.
48. Wetzel C, Tissot A, Kollar LM, Hillard PA, Stone R, Kahn JA. 2007. Development of an HPV educational protocol for adolescents. J Pediatr Adolesc Gynecol 20:281-287.
49. Zur Hausen H. 2002. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2:342-350.